The use of bone morphogenetic protein in thoracolumbar spine procedures: Analysis of the MarketScan longitudinal database

Spine Journal

Volumn 14, Issue 12, 2014, Pages 2929-2937

  Veeravagu, Anand ^a   Cole, Tyler S ^a   Jiang, Bowen ^a   Ratliff, John K ^a   Gidwani, Risha A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone morphogenetic protein; Cancer; Complications; MarketScan; Spine; Thoracolumbar

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BONE MORPHOGENETIC PROTEIN;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER RISK; CHRONIC PAIN; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELIRIUM; FEMALE; HEART ARRHYTHMIA; HEMATOMA; HOSPITAL READMISSION; HUMAN; INTRAOPERATIVE PERIOD; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; REOPERATION; RETROGRADE EJACULATION; RISK ASSESSMENT; SPINE FUSION; THORACOLUMBAR SPINE; TREND STUDY; WOUND COMPLICATION; WOUND DEHISCENCE; AGED; CASE CONTROL STUDY; EVALUATION STUDY; FACTUAL DATABASE; LUMBAR VERTEBRA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGERY; VERTEBRA;

ADULT; AGED; BONE MORPHOGENETIC PROTEINS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; SPINAL FUSION; THORACIC VERTEBRAE;

EID: 84919392220     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2014.05.010     Document Type: Article

References (40)

1. J. Even, M. Eskander, and J. Kang Bone morphogenetic protein in spine surgery: current and future uses J Am Acad Orthop Surg 20 2012 547 552
2. D.R. Lebl Bone morphogenetic protein in complex cervical spine surgery: a safe biologic adjunct? World J Orthop 4 2013 53 57
3. J.K. Burkus, H.S. Sandhu, and M.F. Gornet Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft Spine 31 2006 775 781
4. E. Carlisle, and J.S. Fischgrund Bone morphogenetic proteins for spinal fusion Spine J 5 6 Suppl 2005 240S 249S
5. M. Boakye, P.V. Mummaneni, and M. Garrett Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein J Neurosurg Spine 2 2005 521 525
6. J.K. Burkus Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004 J Neurosurg Spine 1 2004 254 260
7. J.K. Burkus, S.E. Heim, M.F. Gornet, and T.A. Zdeblick The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies Orthopedics 27 2004 723 728
8. E. Dawson, H.W. Bae, and J.K. Burkus Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial J Bone Joint Surg Am 91 2009 1604 1613
9. S.D. Boden, J. Kang, H. Sandhu, and J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 2002 2662 2673
10. S.D. Boden, T.A. Zdeblick, H.S. Sandhu, and S.E. Heim The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report Spine 25 2000 376 381
11. S.P. Lad, J.H. Bagley, and I.O. Karikari Cancer after spinal fusion: the role of bone morphogenetic protein Neurosurgery 73 2013 440 449
12. J.R. Dimar II, S.D. Glassman, and J.K. Burkus Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned" Spine J 11 2011 1082 1083 author reply 1083-6
13. M.D. Helgeson, R.A. Lehman Jr., and J.C. Patzkowski Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion Spine J 11 2011 507 510
14. S.K. Mirza Folly of FDA-approval studies for bone morphogenetic protein Spine J 11 2011 495 499
15. D.M. Spengler Resetting standards for sponsored research: do conflicts influence results? Spine J 11 2011 492 494
16. E.J. Carragee, E.L. Hurwitz, and B.K. Weiner A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 2011 471 491
17. J.D. Kang Another complication associated with rhBMP-2? Spine J 11 2011 517 519
18. S.D. Glassman, J.L. Gum, and C.H. Crawford III Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear Spine J 11 2011 522 526
19. E.J. Carragee, R.M. Baker, and E.C. Benzel A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research Spine J 12 2012 877 880
20. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27
21. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
22. E.J. Bergstralh, and J.L. Kosanke Computerized matching of controls. Section of Biostatistics Technical Report 56 1995 Mayo Foundation Rochester, MN
23. R. Fu, S. Selph, and M. McDonagh Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis Ann Intern Med 158 2013 890 902
24. M.C. Simmonds, J.V. Brown, and M.K. Heirs Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data Ann Intern Med 158 2013 877 889
25. K. Singh, K. Ahmadinia, and D. Park Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature Spine 39 2014 91 101
26. G.C. Comer, M.W. Smith, and E.L. Hurwitz Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study Spine J 12 2012 881 890
27. Food and Drug Administration OaRDAP. Executive summary for P050036 Medtronic's AMPLIFY rhBMP-2 Matrix. 2010. Available at: http://wwwfdagov/downloads/advisorycommittees/committeesmeetingmaterials/medicaldevices/medicaldevicesadvisorycommittee/orthopaedicandrehabilitationdevicespanel/ucm220079pdf.
28. J.G. Devine, J.R. Dettori, and J.C. France The use of rhBMP in spine surgery: is there a cancer risk? Evid Based Spine Care J 3 2012 35 41
29. G.S. Cooper, and T.D. Kou Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2) Spine 38 2013 1862 1868
30. K.S. Cahill, J.H. Chi, and M.W. Groff Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein Spine 36 2011 2354 2362
31. R.A. Deyo, A. Ching, and L. Matsen Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges Spine 37 2012 222 230
32. D.C. Classen, R. Resar, and F. Griffin 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured Health Aff (Millwood) 30 2011 581 589
33. P.R. Rosenbaum, and D.B. Rubin The bias due to incomplete matching Biometrics 41 1985 103 116
34. J.R. Dimar II, S.D. Glassman, and J.K. Burkus Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis J Bone Joint Surg Am 91 2009 1377 1386
35. J.R. Dimar, S.D. Glassman, K.J. Burkus, and L.Y. Carreon Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft Spine 31 2006 2534 2539 discussion 2540
36. D.S. Baskin, P. Ryan, and V. Sonntag A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate Spine 28 2003 1219 1224 discussion 1225
37. J.K. Burkus, M.F. Gornet, C.A. Dickman, and T.A. Zdeblick Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages J Spinal Disord Tech 15 2002 337 349
38. E.J. Carragee, K.A. Mitsunaga, E.L. Hurwitz, and G.J. Scuderi Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study Spine J 11 2011 511 516
39. J.A. Rihn, R. Patel, and J. Makda Complications associated with single-level transforaminal lumbar interbody fusion Spine J 9 2009 623 629
40. P.R. Dagostino, R.G. Whitmore, and G.A. Smith Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008 Spine J 14 2014 20 30